UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Rule 14d-101)
(Amendment No. 2)
SOLICITATION/RECOMMENDATION STATEMENT
UNDER SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
GENMARK DIAGNOSTICS, INC.
(Name of Subject Company)
GENMARK
DIAGNOSTICS, INC.
(Name of Person(s) Filing Statement)
COMMON STOCK, PAR VALUE $0.0001 PER SHARE
(Title of Class of Securities)
372309104
(CUSIP Number
of Class of Securities)
Scott Mendel
Chief Executive Officer and President
GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, California 92008
Telephone: (760) 448-4300
Facsimile: (760) 683-6876
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications
on Behalf of the Person(s) Filing Statement)
With copies to:
Eric J. Stier, Esq.
Senior Vice President, General Counsel and Secretary
GenMark Diagnostics, Inc.
5964 La Place Court
Carlsbad, California 92008
Telephone: (760) 448-4327
Facsimile: (760) 683-6876
Patrick OMalley, Esq.
4365 Executive Drive, Suite 1100
San Diego, CA 92121
Telephone: (858) 677-1400
☐
|
Check the box if the filing relates solely to preliminary communications made before the commencement of a
tender offer.
|